NYSE · BDXHealthcareSurgical Instruments

Becton, Dickinson and financials

$181.97−1.01%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Sep 30
FY24
Sep 30
FY23
Sep 30
FY22
Sep 30
FY21
Sep 30
FY20
Sep 30
FY19
Sep 30
FY18
Sep 30
FY17
Sep 30
FY16
Sep 30
Revenue$21.84B$20.18B$19.37B$18.87B$19.13B$16.07B$17.29B$15.98B$12.09B$12.48B
Gross profit$9.93B$9.13B$8.17B$8.48B$8.63B$6.80B$8.29B$7.27B$5.96B$5.99B
Gross margin45.4%45.2%42.2%44.9%45.1%42.3%47.9%45.5%49.3%48.0%
Operating income$2.97B$2.62B$1.90B$2.28B$2.25B$912.0M$1.76B$1.51B$1.52B$1.43B
Net income$1.68B$1.71B$1.42B$1.69B$2.00B$767.0M$1.08B$159.0M$1.03B$976.0M
Net margin7.7%8.4%7.4%9.0%10.5%4.8%6.3%1.0%8.5%7.8%
Diluted EPS$5.82$5.86$4.94$5.88$6.85$2.71$3.94$0.60$4.60$4.49
EBITDA$5.84B$5.36B$4.50B$4.70B$4.66B$3.33B$4.49B$4.23B$2.96B$3.27B
Operating cash flow$3.43B$3.80B$2.99B$2.63B$4.65B$2.94B$3.33B$2.87B$2.55B$2.56B
Free cash flow$2.67B$3.07B$2.12B$1.66B$3.45B$2.17B$2.37B$1.97B$1.82B$1.87B
Diluted shares288.5M291.0M288.4M287.4M292.1M282.4M274.8M264.6M223.6M217.5M

Balance sheet

Period endSep 30Sep 30Sep 30Sep 30Sep 30Sep 30
Cash & equivalents$567.0M$1.72B$1.42B$1.01B$2.28B$2.83B
Short-term investments$8.0M$445.0M$8.0M$8.0M$12.0M$20.0M
Total debt$19.18B$20.11B$15.88B$16.07B$17.61B$17.93B
Total assets$55.33B$57.29B$52.78B$52.93B$53.87B$54.01B
Total liabilities$29.93B$31.40B$26.98B$27.65B$30.19B$30.25B
Shareholders' equity$25.39B$25.89B$25.80B$25.28B$23.68B$23.77B

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology